The First Affiliated Hospital of Zhengzhou University — Zhengzhou

Public research footprint of The First Affiliated Hospital of Zhengzhou University, compiled from the ClinicalTrials.gov public registry.

767

Registered studies

389

Active

239

Recruiting now

193

Completed

Stopped or withdrawn

Most-studied conditions

Mantle Cell Lymphoma · B-cell Non-Hodgkin Lymphoma (B-NHL) · Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Non-Small Cell Lung Cancer (NSCLC)

Recently updated registry entries

NCT03888105 — A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients… (Active Not Recruiting)
NCT07740564 — Phase III Study of OT202 in Treating Moderate to Severe Dry Eye (Not Yet Recruiting)
NCT05920356 — A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The First Affiliated Hospital of Zhengzhou University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.